Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1982-02-02
1984-03-27
Hazel, Blondel
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 88, 536 11, 435101, A61K 3902, C08B 3700, C12P 1904
Patent
active
044394225
ABSTRACT:
Pure Group B Streptococcus antigen and Group B, Type III Streptococcus antigen are isolated, separated and purified from the culture medium in which the Group B, Type III Streptococcus are grown. The process involves (a) culturing the Group B, Type III Streptococcus in a nutrient medium, free of animal proteins and lipids, containing from 1 to 5% by weight glucose and from 0.04 M to 0.16 M phosphates; (b) separating the bacterial cells from the culture medium; (c) extracting and separating the Group B antigens and the Type III antigens from the culture medium supernatant by means of an anion exchanger; and, (d) purifying the resulting antigenic materials by chromatography on an agarose gel column. The antigens can be used as vaccines against infections caused by Group B or Group B, Type III Streptococcus.
REFERENCES:
patent: 4207414 (1980-06-01), Kasper
Kasper, D., et al., J. Immunol., vol. 121, pp. 1096-1105, 1978.
Baker, C., et al., J. Exp. Med., vol. 143, pp. 258-270, 1976.
Baker, C., et al., J. Clin. Invest., vol. 61, pp. 1107-1110, 1978.
Baker, C., et al., Infect. and Immun., vol. 13, pp. 189-194, 1976.
Baker, C., et al., J. Inf. Dis., vol. 136, pp. 137-152, 1977.
Baker, C., et al., New England Journal of Medicine, vol. 294, pp. 753-756, 1976.
Russell et al., J. Immunol., vol. 109, pp. 90-96, 1972.
Lancefield et al., J. Hygcamb., vol. 64, pp. 191-203, 1966.
Wittner, et al., J. Bact., vol. 89, pp. 398-402, 1965.
Curtis et al., Fed. Proc., vol. 23, p. 191, 1964.
Lancefield, J. Exp. Med., vol. 67, pp. 25-40, 1938.
Lancefield, J. Exp. Med., vol. 59, pp. 441-457, 1934.
Carey Roberta B.
Eisenstein Toby K.
Shockman Gerald D.
Swenson Robert M.
Hazel Blondel
Research Corporation
LandOfFree
Group B Streptococcus antigens and vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Group B Streptococcus antigens and vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Group B Streptococcus antigens and vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1755592